| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca45d719b6774f7cbaf1ddd7ac03a5de |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2014-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0faaa98a7d54d54990f1f804b405b90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5d4f07dc4dc3c5b9921369f37a0de3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc38dcf64c971ee27c9871479c60a832
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9c5d115f09bde5b0c05b9be04cbe687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ee155fbdd6f03f21b17ee1d77453b95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9129cde9cee59aebf0e4ab357ce2f5b |
| publicationDate |
2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014157107-A1 |
| titleOfInvention |
Polypeptide having sialylated sugar chains attached thereto |
| abstract |
[Problem] To provide a polypeptide which has highly homogeneous sialylated sugar chains attached thereto and has an interferon β activity.n[Solution] A sugar chain-containing polypeptide that is selected from the group consisting of (1) to (4):n(1) a polypeptide which comprises the amino acid sequence represented by SEQ ID NO:1;n(2) a polypeptide which comprises an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO:1 by deletion, substitution or addition of one to several amino acids;n(3) a polypeptide that is an analog of interferon β; andn(4) a polypeptide that has an 80% or higher homology with the polypeptide comprising the amino acid sequence represented by SEQ ID NO:1,nwherein amino acids at 4-6 positions are substituted with amino acids having sugar chains attached thereto, and all of non-reducing ends of these sugar chains are sialylated. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018003983-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023145812-A1 |
| priorityDate |
2013-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |